This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Payor Perspective: Discussing reimbursement for GLP-1 drugs based on cardiovascular benefits with a focus on the SELECT trial

Ticker(s): NVO, LLY

Who's the expert?

Institution: Bon Secours Mercy Health

  • Manager of Pharmacy Benefits at Bon Secours Mercy Health
  • Accomplished pharmacy professional specialized in optimizing pharmacy benefit plans for the employer and external clients, leading formulary management, prior authorization processes, and clinical appeals coordination.
  • Recognized for comprehensive pharmacy benefit plan designs, collaborating with stakeholders to minimize costs while ensuring high-quality patient care.

Interview Goal
On this call we will be discussing how payor's are strategizing reimbursement for GLP-1 drugs for the prevention of heart disease based on cardiovascular benefits shown in the SELECT trial.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.